Privia Health Group, Inc. · NASDAQ:PRVA
Privia Health — Investor Presentation (June 2021)
34 slides from Privia Health's investor presentation, Jun 16, 2021
Slide 1: Investor Presentation June 2021 - Empowering Physicians
PROPRIETARY AND CONFIDENTIAL Investor Presentation June 2021 Empowering Physicians TRANSFORMING HEALTHCARE
Slide 2: Forward-Looking Statements
2 Forward-Looking Statements This presentation contains forward-looking statements that express the Company’s opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results that include, but are not limited to: 2021 financial guidance and oth
Slide 3: Our Mission and Vision
3 WE KNOW doctors. WE ENABLE better outcomes. TOGETHER we move markets. OUR MISSION Transform healthcare to enable doctors and their teams to focus on keeping people healthy WHO WE ARE National physician platform transforming the healthcare delivery experience WHAT WE DO Provide tailored solutions f
Slide 4: Privia Health: Investment Highlights
4 Privia Health: Investment Highlights Proven and Scalable for All Provider Types, Patients & Reimbursement Models Multiple Drivers for Future Growth with a Large TAM Comprehensive Technology Solution Built for Providers Profitable, Capital -Efficient Profile Aligned with Provider Financial Success
Slide 5: Moving Markets Toward Value-Based Care At Scale
5 Moving Markets Toward Value -Based Care At Scale Enter Market Align with anchor medical groups and health systems to transition markets to value Organize Providers Form high performance medical groups Develop network of leading primary care providers and specialists Drive Improvements Adva
Slide 6: Building a National Footprint
6 Building a National Footprint Privia Timeline Mid-Atlantic Tennessee Georgia Florida North Texas Gulf Coast Texas Launched Mid-Atlantic Market Launched Women’s Health Platform Launched Tennessee Market & Privia Pediatrics Platform Launched North Texas Market Launched Georgia & Gulf Coast Markets L
Slide 7: Significant Whitespace Exists Across Our End Markets
7 Significant Whitespace Exists Across Our End Markets Source: KaiserFamilyFoundation, Nephron Research. “The Dawn of PhysicianEnablement: Defining Healthcare in the 2020 s.” January20, 2021. Statista. The Privia Solution Addresses a Large Market Ripe for Disruption With Significant Opportunity for
Slide 8: Proven, Scalable and Flexible Operating Model
8 Proven, Scalable and Flexible Operating Model • Single Tax-ID Medical Group in each local market – a primary care centric delivery network in each market • Management services and clinical organization enabled by the Privia Technology Solution • Market specific strategies —Accountable Care Organiz
Slide 9: Differentiated Model Organizes Cost-Efficient Provider Networks
9 Differentiated Model Organizes Cost -Efficient Provider Networks Primary care centric single-TIN Medical Group; Medical Group governance structure allows providers to build a clinical culture adapting to consumers’ and a region’s unique needs Cutting-edge, interoperable technology platform designe
Slide 10: Tech-Driven Physician Enablement Platform At Scale
10 Tech-Driven Physician Enablement Platform At Scale 3M+ Patients 80M+ Addressable Population (Current Markets) 95% Average Provider Retention 85 Patient NPS 54 Provider NPS Patient Population Satisfaction Scale 2,648 Implemented Providers 6 + D.C. States 650+ Care Center Locations $1.3B+ 2020 Prac
Slide 11: Differentiated Value-Based Care (VBC) Opportunity
11 Differentiated Value -Based Care (VBC) Opportunity • VBC participation across Commercial, Medicare Advantage, Medicare & Medicaid • Significant opportunity to move attributed lives into full-risk arrangements over time • Interests aligned with provider groups sharing upside/downside risk with Pri
Slide 12: Methodical Process Helps Providers Move Towards Value
12 Methodical Process Helps Providers Move Towards Value
Slide 13: Proprietary, End-to-End Tech Solution Enables Providers
13 Proprietary, End-to-End Tech Solution Enables Providers to Practice More Efficiently and Focus on Patient Care Proprietary end-to-end, cloud-based technology solution enabling scalable operations across providers and multiple markets Enhances workflows in both fee-for-service and value-based care
Slide 14: The Privia Technology Solution Creates an Integrated Experience
14 The Privia Technology Solution Creates an Integrated Experience for Providers and Patients Old Way The Privia Way Privia manages complexity to create a unified workflow and experience for providers, staff, and patients Confusion and disorganization as a result of an onslaught of information from
Slide 15: Delivering Demonstrable Value to Our Providers
15 Delivering Demonstrable Value to Our Providers Fee-for-Service Rate Lift Expense Savings on EMR / PMS & Group Purchasing Net Realization Rate Improvement Through Robust Revenue Cycle Management Enhanced Provider Productivity & Same- Store Patient Volume Value-Based Care Revenue: Commercial, MSSP,
Slide 16: Positioned to Monetize Our Platform and Drive Growth
16 Positioned to Monetize Our Platform and Drive Growth — Same store growth of patients attributed to value based contracts — Moving existing attribution into full risk value based programs, such as direct contracting and fully capitated contracts — Develop new products with aligned payers — Add pri
Slide 17: Privia Health: Economic Model
17 Privia Health: Economic Model 1 1 2 3 4 4 Practice Collections Collections from Non- Owned Medical Groups GAAP Revenue Physician and Practice Expense Care Margin Cost of Platform Platform Contribution Sales and Marketing G&A Adjusted EBITDA 1 Practice Collections: FFS collections and VBC payments
Slide 18: The Privia Platform is Scaling Rapidly
18 The Privia Platform is Scaling Rapidly * The 2021 guidance contained in this slide represents midpoint of guidance provided on May 27, 2021, which is not being updated or confirmed hereby. LT Growth Target: 20%+ Q1: 2,648 Q1: 721
Slide 19: Improving Margins Over Time
19 Improving Margins Over Time LT Growth Target: ~30% - ~40% LT Margin Target: 30% - 35% of Care Margin LT Growth Target: 20%+ * The 2021 guidance contained in this slide represents midpoint of guidance provided on May 27, 2021, which is not being updated or confirmed hereby. % PracticeCollections 6
Slide 20: FY'21 Guidance as of May 27, 2021
20 FY’21 Guidance as of May 27, 2021 * FY 2021 guidance was provided on May 27, 2021, and is not being updated or confirmed hereby. ($ in millions) FY 2020 Actual FY 2021 Guidance Y - Y % Change from FY 2020 Low High Low High Implemented Providers 2,550 2,850 2,900 11.8% 13.7% Attributed Lives 682,0
Slide 21: Other FY'21 Guidance Assumptions
21 Other FY’21 Guidance Assumptions • Fully diluted weighted average shares outstanding of 110 - 120M, including pre-IPOperiod • Non-cash stock compensation expense of $195 - $205M in 2Q’21 and $245 - $255M for FY’21* • Pro forma 1Q’21cash of ~$293.9M**with total debt of $33.9M • Capital expenditure
Slide 22: 1Q'21 Performance
22 261 264 281 491 418 440 752 682 721 1Q'20 4Q'20 1Q'21 $327.4 $344.0 1Q'20 1Q'21 $7.1 $9.9 1Q'20 1Q'21 $20.3 $25.5 1Q'20 1Q'21 2,528 2,550 2,648 1Q'20 4Q'20 1Q'21 1Q’21 Performance Implemented Providers (as of end of period) Attributed Lives (‘000s, as of end of period)1 Platform Contribution ($mm
Slide 23: Privia Health: Investment Highlights
23 Privia Health: Investment Highlights Proven and Scalable for All Provider Types, Patients & Reimbursement Models Multiple Drivers for Future Growth with a Large TAM Comprehensive Technology Solution Built for Providers Profitable, Capital -Efficient Profile Aligned with Provider Financial Success
Slide 24: Appendix
fN ar, APPENDIX
Slide 25: Case Study: Driving Performance for Physician Group "A"
25 Case Study: Driving Performance for Physician Group “A” Partnership 1 1. From 2014 to 2020.
Slide 26: Case Study: Driving Growth in Our Mid-Atlantic Market
26 Case Study: Driving Growth in Our Mid-Atlantic Market 1. From 2014 to 2020 2. Cohort of 76 Mid-Atlantic primary care providers who have been a part of Privia for at least five years
Slide 27: Case Study: Establishing an Anchor Partnership in a New Market
27 Case Study: Establishing an Anchor Partnership in a New Market with Health System “A” and Driving Growth
Slide 28: Reconciliation of Operating Income to Care Margin
28 Reconciliation of Operating Income to Care Margin 1 (1) Care Margin is total revenue less the sum of physician and practice expense.
Slide 29: Reconciliation of Operating Income to Care Margin
29 Reconciliation of Operating Income to Care Margin 1 (1) Care Margin is total revenue less the sum of physician and practice expense.
Slide 30: Reconciliation of Operating Income to Platform Contribution
30 Reconciliation of Operating Income to Platform Contribution 2 (2) Platform Contribution is total revenue less the sum of physician and practice expense and cost of platform.
Slide 31: Reconciliation of Operating Income to Platform Contribution
31 Reconciliation of Operating Income to Platform Contribution 2 (2) Platform Contribution is total revenue less the sum of physician and practice expense and cost of platform.
Slide 32: Reconciliation of Net Income to Adjusted EBITDA
32 Reconciliation of Net Income to Adjusted EBITDA 3 (3) Adjusted EBITDAis net income (loss)attributable to Privia Health Group, Inc. shareholders and subsidiaries excluding minority interests, provision (benefit) for income taxes, interest income, interest expense, depreciation and amortization, st
Slide 33: Reconciliation of Net Income to Adjusted EBITDA
33 Reconciliation of Net Income to Adjusted EBITDA 3 (3) Adjusted EBITDAis net income (loss)attributable to Privia Health Group, Inc. shareholders and subsidiaries excluding minority interests, provision (benefit) for income taxes, interest income, interest expense, depreciation and amortization, st
Slide 34: Thank You
34 Thank You PriviaHealth.com Contact: Robert P. Borchert SVP, Investor & Corporate Communications robert.borchert@priviahealth.com Phone: 817.783.4841
Privia Health Group — Investor Presentation (June 2021) on 6ix